Elastomeric Infusion Pumps Market 2022
The global Elastomeric Infusion Pumps Market is all set to witness a CAGR of 9% in the next decade. It is expected to reach US$ 2.1 Bn by the year 2030. With digitized communication channels making a beeline to the healthcare vertical, the advanced clinics are into virtual consultation mode, and this scenario is expected to continue even going forward. Regulatory approvals for this type of communication are on the way. Close to 70% of the public hospitals worldwide are being asked to adopt digital means. This would be the scene with healthcare vertical in the subsequent period.
Rising volume of surgical procedures globally as well as increasing need for post-operative analgesics for moderate to severe pain has given rise to augmented demand for elastomeric infusion pumps. The global elastomeric infusion pumps market was valued at US$ 981.5 Mn in 2021, and is set to project a CAGR of to 9% over the forecast period (2022-2030).
Get Free Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/11032
Patients displaying the inability to ingest oral analgesics benefit through the adoption of elastomeric infusion pumps, thus supporting the growth of the market, owing to a large rate of intensive care admissions worldwide. Rapid growth as well as rising industrialization activities in emerging economies, including the East African region, territories of Eastern Europe, and Asia Pacific has boosted support for production, research, and development of cost-effective medical devices.
Availability of an established manufacturing setup, low-cost labor, and competent and skilled workers in countries such as China are further providing a push for lucrative growth projections for elastomeric infusion pump manufacturers.
Preference toward the adoption and utilization of elastomeric pumps as an alternative to electronic pumps for pain management in hospital and medical settings has gained traction, thus exhibiting a surge to the overall sales value of the global market. Key factors supporting growing adoption of elastomeric infusion pumps include ease of usage, cost effectiveness, discreteness, and lower risk of casualty.
Furthermore, extensive application of elastomeric infusion pumps in oncological care by providing support during the delivery of drugs for chemotherapy at ambulatory care centers and home care settings is likely to propel market growth over the forecast period. Elastomeric infusion pump producers are also progressively building focus on bundling accompanying accessories and IV drugs to increase their penetration into the global market.
Company Profiles:
- Baxter International, Inc.
- Fresenius Kabi AG
- B. Braun Melsungen AG
- Ambu A/S
- Leventon, S.A.U.
- Nipro Corporation
- Terumo Corporation
- Avanos Medical, Inc.
Request for Methodology @ https://www.persistencemarketresearch.com/methodology/11032
Key Takeaways from Market Study
- By product, continuous rate elastomeric pumps are expected to hold over 68% market value share by the end of 2030.
- Pain management was the leading treatment with more than 1/3 market share in 2021.
- Hospitals dominated the end user segment with a share of around 39.4% in 2021.
- By region, Asia Pacific leads the global market and is estimated to grow 2.1X by 2030.
“Increasing administration of drugs by IV for faster relief and emergence of alternatives for drug administration are set to propel demand growth of elastomeric infusion pumps,” says an analyst of Persistence Market Research.
Market Competition
Key players such as Avanos Medical & B. Braun Melsungen AG cover a larger share in the market, and seek growth approaches that include the production of novel infusion systems as well as activities of strategic partnerships with other existing players to advance their market scope and penetrate into emerging economies.
- In April 2020, B. Braun Medical Inc. announced US FDA-EUA of its Perfusor® Space Syringe Infusion Pump, Outlook® ES Pump systems, and Infusomat® Space Volumetric Infusion Pump. These pumps are used to treat patients of all ages suffering from COVID-19 by delivering continuous nebulized medications via tracheal route into a nebulizer.
- In April 2019, Avanos Medical acquired FDA clearance for its ON-Q Bolus pump, which is used for pain management in patients post-surgery, without using opioids.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the elastomeric infusion pumps market in its latest study, presenting historical demand assessment of 2012 – 2021 and projections for 2022 – 2030.
The research study is based on product (continuous rate elastomeric pumps and variable rate elastomeric pumps), treatment (pain management, antibiotic/antiviral, chemotherapy, and others), and end user (hospitals, ambulatory surgical centers, home care settings, clinics, and others), across five key regions of the world.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/11032
Key Questions Answered in the Elastomeric Infusion Pumps Market Report
How is the Elastomeric Infusion Pumps Market expected to grow over the projected period?
What direction is the Elastomeric Infusion Pumps Market expected to take in terms of volume and value during the forecast period?
What is the impact of macroeconomic factors on the Elastomeric Infusion Pumps Market in future?
What are the key market drivers in the Elastomeric Infusion Pumps Market?
What are significant opportunities and improvement areas for Elastomeric Infusion Pumps Market manufacturers?
What are the key developments and trends taking over the Elastomeric Infusion Pumps Market?
Which are the emerging countries that are expected to create significant growth opportunities in the Elastomeric Infusion Pumps Market?
If you have any special requirements, please let us know and we will offer you the report as you want and also We Provide you Table of Content.
Related Reports:
Telemedicine Market – Global telemedicine market slated for over 17% CAGR in terms of revenues, over 2019-2029.
E Clinical Solution Market – Global e-clinical solution software market is estimated to be surpass USD 6,515 Mn by 2020, expanding at 13.8% CAGR with healthy revenue, valuation, trends & forecast.
About us:
PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com